Regen BioPharma Inc Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regen BioPharma Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Regen BioPharma Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$108K, a 26.8% decline year-over-year.
  • Regen BioPharma Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$391K, a 46.1% increase year-over-year.
  • Regen BioPharma Inc annual Operating Income (Loss) for 2023 was -$687K, a 102% decline from 2022.
  • Regen BioPharma Inc annual Operating Income (Loss) for 2022 was -$340K, a 69.2% decline from 2021.
  • Regen BioPharma Inc annual Operating Income (Loss) for 2021 was -$201K, a 4.08% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$687K -$347K -102% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-20
2022 -$340K -$139K -69.2% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-20
2021 -$201K +$8.55K +4.08% Oct 1, 2020 Sep 30, 2021 10-K 2022-11-15
2020 -$209K +$547K +72.3% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-22
2019 -$757K +$669K +46.9% Oct 1, 2018 Sep 30, 2019 10-K 2021-08-04
2018 -$1.43M +$1.09M +43.2% Oct 1, 2017 Sep 30, 2018 10-K 2021-06-21
2017 -$2.51M +$446K +15.1% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-27
2016 -$2.96M -$978K -49.4% Oct 1, 2015 Sep 30, 2016 10-K 2016-12-21
2015 -$1.98M -$1.27M -180% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-21
2014 -$706K -$387K -121% Oct 1, 2013 Sep 30, 2014 10-K/A 2017-04-28
2013 -$320K Oct 1, 2012 Sep 30, 2013 10-K 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.